Teacher Retirement System of Texas Acquires 9,114 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Teacher Retirement System of Texas lifted its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 378,634 shares of the healthcare conglomerate’s stock after purchasing an additional 9,114 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Teacher Retirement System of Texas’ holdings, making the stock its 12th largest holding. Teacher Retirement System of Texas’ holdings in UnitedHealth Group were worth $193,092,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Outfitter Financial LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $25,000. Advocacy Wealth Management Services LLC lifted its holdings in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares during the period. Cascade Investment Advisors Inc. lifted its holdings in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 30 shares during the period. Tortoise Investment Management LLC lifted its holdings in UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 23 shares during the period. Finally, Leverty Financial Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $34,000. 87.48% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $535.06 on Friday. The company has a market capitalization of $500.48 billion, a PE ratio of 27.94, a price-to-earnings-growth ratio of 1.65 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77. The business’s fifty day moving average is $506.46 and its 200 day moving average is $499.44. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same period in the previous year, the business earned $4.70 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were issued a dividend of $1.65 per share. The ex-dividend date of this dividend was Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction dated Friday, July 29th. The stock was sold at an average price of $541.53, for a total value of $7,138,989.99. Following the completion of the sale, the chief financial officer now directly owns 141,508 shares in the company, valued at $76,630,827.24. The disclosure for this sale can be found here. Insiders have sold a total of 130,144 shares of company stock valued at $69,269,555 over the last ninety days. 0.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research reports. Oppenheimer increased their target price on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Sanford C. Bernstein lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. BMO Capital Markets raised their price objective on UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a research report on Wednesday, May 25th. Finally, UBS Group increased their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Three research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $582.50.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.